rheumatoid arthritis
adult-onset Still's disease
cyotkine
Date | Time | Room | Session Title | Lecture Title |
---|---|---|---|---|
May 19 | 08:00-08:40 | Room Grand Ballroom 103 | [Breakfast Symposium 6 - Eisai] Introducing Jyseleca (Filgotinib): JAK1-preferential Inhibitor | The efficacy and safety of Jyseleca in RA: Based on clinical trials and real world experience in Japan |